Financhill
Sell
23

PAVM Quote, Financials, Valuation and Earnings

Last price:
$0.58
Seasonality move :
5.93%
Day range:
$0.58 - $0.60
52-week range:
$0.54 - $1.90
Dividend yield:
0%
P/E ratio:
0.86x
P/S ratio:
8.83x
P/B ratio:
0.55x
Volume:
102.8K
Avg. volume:
137.1K
1-year change:
-48.05%
Market cap:
$10.4M
Revenue:
$3M
EPS (TTM):
$0.70
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue -- $500K $377K $2.5M $3M
Revenue Growth (YoY) -- -- -24.6% 550.4% 22.15%
 
Cost of Revenues -- $585K $3.6M $6.4M $4.8M
Gross Profit -- -$85K -$3.2M -$4M -$1.8M
Gross Profit Margin -- -17% -858.62% -161.83% -61.6%
 
R&D Expenses $11M $19.8M $25.3M $14.3M $5.9M
Selling, General & Admin $12.4M $34.3M $60.7M $48.5M $36.2M
Other Inc / (Exp) -$11.8M -$1.7M -$11M -$10.4M $72.6M
Operating Expenses $23.4M $54.3M $87.9M $64.8M $42.5M
Operating Income -$23.4M -$54.4M -$91.1M -$68.8M -$44.4M
 
Net Interest Expenses -- -- $1.1M $84K --
EBT. Incl. Unusual Items -$35.9M -$56.1M -$103.2M -$79.3M $28.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$35.9M -$56.1M -$103.2M -$79.3M $28.4M
 
Minority Interest in Earnings $1.6M $5.8M $14.3M $15.1M $11.4M
Net Income to Common Excl Extra Items -$34.3M -$50.3M -$89M -$64.2M $39.8M
 
Basic EPS (Cont. Ops) -$10.95 -$9.75 -$15.03 -$9.16 $3.30
Diluted EPS (Cont. Ops) -$10.95 -$9.75 -$15.03 -$9.16 $0.50
Weighted Average Basic Share $3.2M $5.2M $5.9M $7.2M $9.7M
Weighted Average Diluted Share $3.2M $5.2M $5.9M $7.2M $65.3M
 
EBITDA -$35.8M -$55.9M -$99.5M -$75.7M $29.7M
EBIT -$35.8M -$56.1M -$102M -$78.7M $28.5M
 
Revenue (Reported) -- $500K $377K $2.5M $3M
Operating Income (Reported) -$23.4M -$54.4M -$91.1M -$68.8M -$44.4M
Operating Income (Adjusted) -$35.8M -$56.1M -$102M -$78.7M $28.5M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue -- $189K $446K $1M $8K
Revenue Growth (YoY) -- -- 135.98% 126.46% -99.21%
 
Cost of Revenues -- $369K $1.3M $1.7M $36K
Gross Profit -- -$180K -$900K -$734K -$28K
Gross Profit Margin -- -95.24% -201.79% -72.67% -350%
 
R&D Expenses $3.3M $5.9M $4.1M $1.9M $787K
Selling, General & Admin $4.8M $13.4M $14.9M $11M $4.6M
Other Inc / (Exp) -$2M -- -$1.8M -$4.5M $24M
Operating Expenses $8.1M $19.5M $19.5M $13.3M $5.4M
Operating Income -$8.1M -$19.6M -$20.4M -$14M -$5.4M
 
Net Interest Expenses -- -- $62K -- --
EBT. Incl. Unusual Items -$10.1M -$19.6M -$22.2M -$18.5M $18.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$10.1M -$19.6M -$22.2M -$18.5M $18.6M
 
Minority Interest in Earnings $679K $2.8M $4.3M $3.3M $345K
Net Income to Common Excl Extra Items -$9.4M -$16.9M -$17.9M -$15.2M $19M
 
Basic EPS (Cont. Ops) -$1.95 -$3.00 -$2.78 -$2.62 $1.28
Diluted EPS (Cont. Ops) -$1.95 -$3.00 -$2.78 -$2.62 $0.34
Weighted Average Basic Share $4.9M $5.8M $6.5M $8.7M $13.9M
Weighted Average Diluted Share $4.9M $5.8M $6.5M $8.7M $52.5M
 
EBITDA -$8.1M -$19.4M -$21.3M -$17.9M $18.7M
EBIT -$8.1M -$19.6M -$22M -$18.5M $18.6M
 
Revenue (Reported) -- $189K $446K $1M $8K
Operating Income (Reported) -$8.1M -$19.6M -$20.4M -$14M -$5.4M
Operating Income (Adjusted) -$8.1M -$19.6M -$22M -$18.5M $18.6M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue -- -- -- $3M $2M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- $6.8M $3.1M
Gross Profit -- -$265K -$4M -$3.8M -$1.1M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $11.7M $22.5M $23.7M $12.2M $4.8M
Selling, General & Admin $14.9M $43M $62.1M $44.6M $29.8M
Other Inc / (Exp) -$4.7M $300K -$12.8M -$13.2M $101.2M
Operating Expenses $26.2M $65.7M $87.9M $58.6M $34.6M
Operating Income -$26.2M -$66M -$91.9M -$62.4M -$35.8M
 
Net Interest Expenses -- -- $1.2M -- --
EBT. Incl. Unusual Items -$31.1M -$65.7M -$105.8M -$75.6M $65.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$31.1M -$65.6M -$105.8M -$75.6M $65.6M
 
Minority Interest in Earnings $1.9M $7.9M $15.8M $14.1M $8.4M
Net Income to Common Excl Extra Items -$29.2M -$57.8M -$90M -$61.5M $74M
 
Basic EPS (Cont. Ops) -$7.95 -$10.80 -$14.81 -$9.03 $6.63
Diluted EPS (Cont. Ops) -$7.95 -$10.80 -$14.81 -$9.03 $0.70
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -$29M -$65.2M -$101.4M -$72.3M $66.3M
EBIT -$29.1M -$65.7M -$104.4M -$75.1M $65.6M
 
Revenue (Reported) -- -- -- $3M $2M
Operating Income (Reported) -$26.2M -$66M -$91.9M -$62.4M -$35.8M
Operating Income (Adjusted) -$29.1M -$65.7M -$104.4M -$75.1M $65.6M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue -- $189K $446K $1M $8K
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- $369K $1.3M $1.7M $36K
Gross Profit -- -$180K -$900K -$734K -$28K
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $3.3M $5.9M $4.1M $1.9M $787K
Selling, General & Admin $4.8M $13.4M $14.9M $11M $4.6M
Other Inc / (Exp) -$2M -- -$1.8M -$4.5M $24M
Operating Expenses $8.1M $19.5M $19.5M $13.3M $5.4M
Operating Income -$8.1M -$19.6M -$20.4M -$14M -$5.4M
 
Net Interest Expenses -- -- $62K -- --
EBT. Incl. Unusual Items -$10.1M -$19.6M -$22.2M -$18.5M $18.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$10.1M -$19.6M -$22.2M -$18.5M $18.6M
 
Minority Interest in Earnings $679K $2.8M $4.3M $3.3M $345K
Net Income to Common Excl Extra Items -$9.4M -$16.9M -$17.9M -$15.2M $19M
 
Basic EPS (Cont. Ops) -$1.95 -$3.00 -$2.78 -$2.62 $1.28
Diluted EPS (Cont. Ops) -$1.95 -$3.00 -$2.78 -$2.62 $0.34
Weighted Average Basic Share $4.9M $5.8M $6.5M $8.7M $13.9M
Weighted Average Diluted Share $4.9M $5.8M $6.5M $8.7M $52.5M
 
EBITDA -$8.1M -$19.4M -$21.3M -$17.9M $18.7M
EBIT -$8.1M -$19.6M -$22M -$18.5M $18.6M
 
Revenue (Reported) -- $189K $446K $1M $8K
Operating Income (Reported) -$8.1M -$19.6M -$20.4M -$14M -$5.4M
Operating Income (Adjusted) -$8.1M -$19.6M -$22M -$18.5M $18.6M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $17.3M $77.3M $39.7M $19.6M $1.2M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- $200K $17K $61K $18K
Inventory -- $493K $261K $539K $266K
Prepaid Expenses $830K $4.7M $3.9M $4.3M $695K
Other Current Assets $855K $33K -- -- --
Total Current Assets $18.9M $82.6M $43.9M $24.5M $2.2M
 
Property Plant And Equipment $82K $1.6M $5.5M $6.1M $2.7M
Long-Term Investments -- -- -- -- $25.6M
Goodwill -- -- -- -- --
Other Intangibles -- $2M $3.4M $1.4M --
Other Long-Term Assets $755K $725K $1.1M $1.1M $208K
Total Assets $19.8M $87M $54M $33.1M $30.7M
 
Accounts Payable $3M $3.3M $2.7M $1.8M $657K
Accrued Expenses $494K $1.1M $1.8M $3.3M $3.7M
Current Portion Of Long-Term Debt $14.7M -- $33.7M $44.2M $29.1M
Current Portion Of Capital Lease Obligations -- -- $1.1M $1.6M $513K
Other Current Liabilities $54K -- -- $777K $362K
Total Current Liabilities $20.3M $7.6M $41.2M $54.2M $35.4M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $20.3M $7.6M $43M $57.1M $37.7M
 
Common Stock $2.6M $2.5M $2.7M $3M $3.3M
Other Common Equity Adj -- -- -- -- --
Common Equity -$641K $59.2M -$12.4M -$56.8M -$5.8M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -$2.4M $17.8M $20.6M $29.8M -$4.5M
Total Equity -$473K $79.4M $10.9M -$24M -$7M
 
Total Liabilities and Equity $19.8M $87M $54M $33.1M $30.7M
Cash and Short Terms $17.3M $77.3M $39.7M $19.6M $1.2M
Total Debt -- -- $33.7M $44.2M $29.1M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Cash and Equivalents $48.5M $64.7M $49.3M $25.5M $2.7M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- $89K $27K $67K $9K
Inventory -- -- $189K $668K $263K
Prepaid Expenses -- $4.8M $4.3M $3.3M $666K
Other Current Assets $2M $364K -- -- --
Total Current Assets $50.5M $71M $53.8M $29.6M $3.6M
 
Property Plant And Equipment -- $5M $7.4M $5.5M $2.5M
Long-Term Investments -- -- -- -- $46.6M
Goodwill -- -- -- -- --
Other Intangibles -- -- $2.9M $1.1M --
Other Long-Term Assets $861K $695K $1.1M $1.1M $51K
Total Assets $51.4M $84.3M $65.3M $37.3M $52.8M
 
Accounts Payable $1.9M $8.2M $1.3M $1.5M $369K
Accrued Expenses $1.1M $3.5M $3.7M $6.7M $2.3M
Current Portion Of Long-Term Debt -- -- $44.3M $45.5M $6.6M
Current Portion Of Capital Lease Obligations -- $873K $1.3M $1.3M $528K
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $3M $17.5M $50.5M $55M $9.8M
 
Long-Term Debt $300K -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $3.3M $19.6M $54.5M $57.8M $11.9M
 
Common Stock $2.7M $2.6M $2.9M $3.1M $28.3M
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- $13.6M $18.2M --
Minority Interest, Total -$2.2M $18.8M $32.9M $48.2M -$6.1M
Total Equity $48M $64.7M $10.8M -$20.6M $40.9M
 
Total Liabilities and Equity $51.4M $84.3M $65.3M $37.3M $52.8M
Cash and Short Terms $48.5M $64.7M $49.3M $25.5M $2.7M
Total Debt -- -- $44.3M $45.5M $6.6M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$35.9M -$56.1M -$103.2M -$79.3M $28.4M
Depreciation & Amoritzation $23K $226K $2.5M $2.9M $1.2M
Stock-Based Compensation $2M $15M $19.5M $11.1M $6.4M
Change in Accounts Receivable -- -$200K $183K -$44K $43K
Change in Inventories -- -- -- -- --
Cash From Operations -$21.9M -$40.6M -$71M -$52M -$33.6M
 
Capital Expenditures -- $1.5M $1.5M $242K $55K
Cash Acquisitions -- -$2.2M -- -- -$16.5M
Cash From Investing -$55K -$3.7M -$4.7M $758K -$16.2M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $17.3M -- $35.2M $10M --
Long-Term Debt Repaid -$600K -$15M -- -$79K -$531K
Repurchase of Common Stock -- -- -$366K -- --
Other Financing Activities -$100K -$7M -- -- --
Cash From Financing $33M $104.3M $38.2M $31.2M $31.3M
 
Beginning Cash (CF) $6.2M $17.3M $77.3M $39.7M $19.6M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $11M $60M -$37.5M -$20.1M -$18.5M
Ending Cash (CF) $17.3M $77.3M $39.7M $19.6M $1.2M
 
Levered Free Cash Flow -$22M -$42.1M -$72.5M -$52.3M -$33.6M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders -$10.1M -$19.6M -$22.2M -$18.5M $18.6M
Depreciation & Amoritzation $12K $216K $727K $586K $43K
Stock-Based Compensation $1.4M $4.8M $4.4M $1.9M $930K
Change in Accounts Receivable -- $111K -$10K -$6K $8K
Change in Inventories -- -- -- -- --
Cash From Operations -$9.2M -$12.3M -$16.4M -$13.1M -$1.6M
 
Capital Expenditures -- $574K $26K $42K $6K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$36K -$574K $974K -$42K -$6K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- $10M -- --
Long-Term Debt Repaid -$15M -- -- -$322K --
Repurchase of Common Stock -- -$329K -- -- --
Other Financing Activities -$1.3M -- -- -- -$109K
Cash From Financing $40.5M $316K $24.9M $19M $3.1M
 
Beginning Cash (CF) $17.3M $77.3M $39.7M $19.6M $1.2M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $31.3M -$12.5M $9.5M $5.9M $1.5M
Ending Cash (CF) $48.5M $64.7M $49.3M $25.5M $2.7M
 
Levered Free Cash Flow -$9.2M -$12.8M -$16.4M -$13.2M -$1.6M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders -$31.1M -$65.6M -$105.8M -$75.6M $65.6M
Depreciation & Amoritzation $32K $430K $3M $2.8M $655K
Stock-Based Compensation $3.1M $18.4M $19.1M $8.6M $5.5M
Change in Accounts Receivable -- -$89K $62K -$40K $57K
Change in Inventories -- -- -- -- --
Cash From Operations -$27.3M -$43.7M -$75.1M -$48.8M -$22M
 
Capital Expenditures -- $1.9M $992K $258K $19K
Cash Acquisitions -- -$2.2M -- -- -$16.5M
Cash From Investing -$89K -$4.3M -$3.2M -$258K -$16.1M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- $45.2M -- --
Long-Term Debt Repaid -$15.4M -- -- -$401K -$209K
Repurchase of Common Stock -- -$329K -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $67.2M $64.1M $62.8M $25.3M $15.3M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $39.8M $16.2M -$15.5M -$23.7M -$22.8M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$27.4M -$45.7M -$76.1M -$49M -$22M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders -$10.1M -$19.6M -$22.2M -$18.5M $18.6M
Depreciation & Amoritzation $12K $216K $727K $586K $43K
Stock-Based Compensation $1.4M $4.8M $4.4M $1.9M $930K
Change in Accounts Receivable -- $111K -$10K -$6K $8K
Change in Inventories -- -- -- -- --
Cash From Operations -$9.2M -$12.3M -$16.4M -$13.1M -$1.6M
 
Capital Expenditures -- $574K $26K $42K $6K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$36K -$574K $974K -$42K -$6K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- $10M -- --
Long-Term Debt Repaid -$15M -- -- -$322K --
Repurchase of Common Stock -- -$329K -- -- --
Other Financing Activities -$1.3M -- -- -- -$109K
Cash From Financing $40.5M $316K $24.9M $19M $3.1M
 
Beginning Cash (CF) $17.3M $77.3M $39.7M $19.6M $1.2M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $31.3M -$12.5M $9.5M $5.9M $1.5M
Ending Cash (CF) $48.5M $64.7M $49.3M $25.5M $2.7M
 
Levered Free Cash Flow -$9.2M -$12.8M -$16.4M -$13.2M -$1.6M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will GoodRX Stock Bounce Back?
Will GoodRX Stock Bounce Back?

GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…

Will FCX Benefit From Tariffs?
Will FCX Benefit From Tariffs?

Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…

Can Levi Stock Double?
Can Levi Stock Double?

Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…

Stock Ideas

Buy
71
Is NVDA Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 59x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 43x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Buy
68
MCRI alert for Jul 18

Monarch Casino & Resort [MCRI] is up 19.81% over the past day.

Sell
41
NEGG alert for Jul 18

Newegg Commerce [NEGG] is up 17.85% over the past day.

Buy
72
MNPR alert for Jul 18

Monopar Therapeutics [MNPR] is up 13.2% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock